Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV000999719 | SCV001156506 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001049452 | SCV001213501 | uncertain significance | Charcot-Marie-Tooth disease, type 2 | 2019-06-04 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with leucine at codon 168 of the AARS protein (p.Pro168Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs763378637, ExAC 0.003%). This variant has been observed in an individual affected with inherited peripheral neuropathy (PMID: 27549087). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |